Trademark Search  /  REINVENTANDO SU ATENCION. REDEFINIENDO EL CANCER.

REINVENTANDO SU ATENCION. REDEFINIENDO EL CANCER.

○ Dead · Abandoned

U.S. federal trademark · Serial No. 88435890

Mark
REINVENTANDO SU ATENCION. REDEFINIENDO EL CANCER.
Status
Abandoned
Serial Number
88435890
Filing Date
May 17, 2019
Class(es)
Class 035, Class 042, Class 044, Class 045

Owners

Baptist Health South Florida
03 · Coral Gables, FL, US
Baptist Health South Florida
03 · Coral Gables, FL, US

Goods & Services

Advertising research; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting public interest and awareness of cancer research and treatment; Association services, namely, promoting the public interest and awareness in cancer research and education

Clinical research in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research for medical purposes in the field of cancer; Scientific study and research in the field(s) of cancer

Health care services for treating cancer; Health care services, namely, wellness programs; Medical diagnosis of cancer; Medical evaluation of cancer; Medical treatment of cancer; Medical analysis services for the diagnosis of cancer; Providing health information in the field of cancer research and treatment; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Wellness and health-related consulting services

Providing patient advocate services in the field of cancer research and prevention

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "REINVENTANDO SU ATENCION. REDEFINIENDO EL CANCER." or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.